Drug:
Reaction: ABDOMINAL PAIN
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138862 |
US |
28 | 2 |
Stoma closure, Diarrhoea, Abdominal pain, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 2 | 25138880 |
US |
||
Pulmonary embolism, Illness, Lung disorder, Abdominal pain, Feeling abnormal, |
||||
RISANKIZUMAB-RZAA, |
||||
| 3 | 25139045 |
PL |
38 | 2 |
Abdominal pain, Headache, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 4 | 25139357 |
AU |
30 | 2 |
Central nervous system lupus, Heart failure with preserved ejection fraction, Renal impairment, Hyperkalaemia, Lupus nephritis, Abdominal pain, Body mass index abnormal, Gout, Haematuria, Serositis, |
||||
IRBESARTAN, ERGOCALCIFEROL, HYDROXYCHLOROQUINE SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DARBEPOETIN ALFA, SULFAMETHOXAZOLE AND TRIMETHOPRIM, METOPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, AZATHIOPRINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, COLCHICINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, PRAZOSIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, |
||||
| 5 | 25139622 |
CA |
1 | |
Small intestinal obstruction, Abdominal pain, Nausea, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 6 | 25139688 |
AU |
||
Renal impairment, Heart failure with preserved ejection fraction, Premature baby, Abdominal pain, Exposure during pregnancy, |
||||
RITUXIMAB, DARBEPOETIN ALFA, SULFAMETHOXAZOLE AND TRIMETHOPRIM, METOPROLOL TARTRATE, METOPROLOL, ALLOPURINOL, AZATHIOPRINE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, COLCHICINE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FUROSEMIDE, HYDRALAZINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, IRBESARTAN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PRAZOSIN HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 7 | 25139691 |
US |
49 | 2 |
Off label use, Weight increased, Chills, Vomiting, Abdominal pain, Eructation, Diarrhoea, Flatulence, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, MONTELUKAST, |
||||
| 8 | 25139784 |
US |
||
Hypothermia, Hypoglycaemia, Abdominal pain, Nausea, Vomiting, Overdose, Intentional product misuse, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, PHENTERMINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 9 | 25139898 |
US |
29 | 2 |
Abdominal pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, LEVOTHYROXINE SODIUM, |
||||
| 10 | 25140249 |
DE |
73 | 2 |
Neutropenia, Neutropenia, Neutropenia, Neutropenia, Neutropenia, Neutropenia, Neutropenia, Thrombocytopenia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Joint stiffness, Pulpitis dental, Diarrhoea, Abdominal pain, Fatigue, Dyspepsia, Back pain, Back pain, Dyspepsia, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, CANDESARTAN, CANDESARTAN, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, LEVOTHYROXINE, |
||||
| 11 | 25140451 |
RU |
20 | 2 |
Skin reaction, Dizziness, Abdominal pain, Vomiting, Diarrhoea, Incorrect route of product administration, |
||||
IRON SUCROSE, |
||||
| 12 | 25140518 |
JO |
||
Cytomegalovirus infection, Candida infection, Diarrhoea, Constipation, Abdominal pain, Gastritis viral, Gastroenteritis bacterial, Hypertension, Hypertensive encephalopathy, Chest pain, Urinary tract infection, Pyelonephritis, Respiratory tract infection, Sepsis, Otitis media acute, Gingivitis, Herpes zoster, Herpes simplex, Haemophilus infection, Varicella zoster virus infection, Fungal skin infection, Viral skin infection, Staphylococcal infection, Dermatitis allergic, Diabetes mellitus, Diabetic ketoacidosis, Hyperkalaemia, Hypokalaemia, Nephropathy toxic, Hydronephrosis, Anaemia, Thrombocytopenia, Leukopenia, Tremor, Psychotic disorder due to a general medical condition, Dehydration, Visual impairment, Oedema peripheral, Tooth abscess, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHYLPREDNISOLONE, |
||||
| 13 | 25140554 |
CN |
69 | 1 |
Hiccups, Blindness transient, Vision blurred, Dizziness, Headache, Abdominal pain, Somnolence, Asthenia, Vomiting, Nausea, Contrast encephalopathy, |
||||
IOHEXOL, IOHEXOL, |
||||
| 14 | 25140590 |
CZ |
44 | 2 |
Metastases to liver, Disease progression, Neutropenia, Abdominal pain, Diarrhoea, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, DENOSUMAB, |
||||
| 15 | 25140630 |
US |
77 | 2 |
Gallbladder disorder, Abdominal pain, Constipation, Fatigue, Pruritus, |
||||
ENCORAFENIB, ENCORAFENIB, BINIMETINIB, BINIMETINIB, |
||||
| 16 | 25140718 |
US |
57 | 2 |
Hypotension, Syncope, Infusion related reaction, Decreased appetite, Abdominal pain, Diarrhoea, Abdominal pain upper, |
||||
LAZERTINIB, AMIVANTAMAB, PANTOPRAZOLE, APIXABAN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DENOSUMAB, LEVETIRACETAM, POLYETHYLENE GLYCOL 3350, |
||||
| 17 | 25141039 |
CA |
60 | 2 |
Abdominal distension, Sputum purulent, Abdominal pain, Constipation, Hypersensitivity, Myalgia, Therapeutic product effect incomplete, Drug intolerance, Asthma, Full blood count abnormal, Cough, Fatigue, Nicotine dependence, Obstructive airways disorder, Secondary immunodeficiency, Wheezing, |
||||
RABEPRAZOLE SODIUM, RABEPRAZOLE, MOXIFLOXACIN HYDROCHLORIDE, PREDNISONE, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, ALBUTEROL SULFATE, ERGOCALCIFEROL, CEFTRIAXONE, CEFTRIAXONE SODIUM, CICLESONIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CICLESONIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, LORAZEPAM, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CALCIUM CARBONATE, CEFUROXIME AXETIL, CITALOPRAM, CITALOPRAM HYDROBROMIDE, HUMAN IMMUNOGLOBULIN G, |
||||
| 18 | 25141113 |
CO |
45 | 2 |
Abdominal distension, Abdominal pain, Papule, Burning sensation, Skin lesion, Hypersensitivity, Eye irritation, Eye pruritus, Acne, Dry eye, Ocular hyperaemia, Rash, Dry skin, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, |
||||
| 19 | 25141161 |
|||
Abdominal pain, Hepatic enzyme increased, |
||||
RUXOLITINIB, |
||||
| 20 | 25141432 |
CA |
64 | 1 |
Colitis ulcerative, Dyspnoea, Abdominal pain, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, CHOLESTYRAMINE, |
||||
| 21 | 25141597 |
CA |
||
Injection site pruritus, Fatigue, Abdominal pain upper, Feeling abnormal, Tremor, Insomnia, Generalised oedema, Pain, Dysstasia, Heart rate increased, Product dose omission issue, Movement disorder, Abdominal pain, Product deposit, Product colour issue, Haemoglobin abnormal, Blood lactate dehydrogenase abnormal, Alcohol withdrawal syndrome, |
||||
PEGCETACOPLAN, PEGCETACOPLAN, PEGCETACOPLAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SILDENAFIL CITRATE, SERTRALINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, FOLIC ACID, |
||||
| 22 | 25141872 |
CA |
68 | 2 |
Gastrointestinal haemorrhage, Haemoglobin decreased, Diarrhoea, Frequent bowel movements, Malaise, Abdominal pain, Haemorrhoids, Flatulence, Arthralgia, |
||||
VEDOLIZUMAB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 23 | 25141977 |
CA |
23 | 2 |
Rectal haemorrhage, Gastrooesophageal reflux disease, Off label use, Gastrointestinal viral infection, Poor venous access, Infrequent bowel movements, Frequent bowel movements, Abdominal pain, Haemorrhoids, Dehydration, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, ALBUTEROL SULFATE, ALBUTEROL, MIRTAZAPINE, RIZATRIPTAN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, MEDROXYPROGESTERONE ACETATE, |
||||
| 24 | 25142100 |
US |
||
Headache, Epistaxis, Tinnitus, Abdominal pain, Balance disorder, Gait disturbance, Pain in extremity, Pollakiuria, Product substitution issue, |
||||
AMLODIPINE BESYLATE, |
||||
| 25 | 25142177 |
US |
2 | |
Colitis ulcerative, Impaired quality of life, Diarrhoea, Infection, Skin irritation, Drug ineffective, Alopecia, Product dose omission issue, Trichorrhexis, Memory impairment, Abdominal pain, Injection site erythema, Respiratory tract infection, Rash, Headache, Fatigue, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, NORELGESTROMIN AND ETHINYL ESTRADIOL, BUDESONIDE, METHYLPHENIDATE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 26 | 25142296 |
BE |
2 | |
Nausea, Overdose, Abdominal pain, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 27 | 25142313 |
CA |
45 | 1 |
Blood calcium decreased, Off label use, Therapeutic product effect incomplete, Swelling, Red blood cell count increased, Myalgia, Malaise, Headache, Fatigue, Haemoglobin increased, Dizziness, Diarrhoea, Blood pressure increased, Abdominal pain, Hypoaesthesia, Vitamin D decreased, Ear infection, |
||||
TESTOSTERONE, TESTOSTERONE, TESTOSTERONE,, OCTREOTIDE ACETATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, CANDESARTAN, CALCIUM, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, |
||||
| 28 | 25142516 |
KW |
||
Abdominal pain, Vomiting, Off label use, Fatigue, Product dose omission issue, Product availability issue, |
||||
PEGCETACOPLAN, |
||||
| 29 | 25142772 |
GR |
38 | 1 |
Abdominal pain, Hyperhidrosis, Vomiting, Dyskinesia, Ill-defined disorder, Pallor, Hypotension, Brugada syndrome, Myalgia, Fatigue, Disturbance in attention, Anxiety, Blood testosterone increased, Loss of consciousness, |
||||
TESTOSTERONE, TESTOSTERONE,, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 30 | 25142774 |
CA |
2 | |
Cholelithiasis, Dyspnoea exertional, Abdominal pain, Migraine, Pain, |
||||
ATOGEPANT, FROVATRIPTAN SUCCINATE, ONABOTULINUMTOXINA, |
||||
| 31 | 25142782 |
US |
83 | 1 |
Abdominal pain, Nausea, Constipation, |
||||
NINTEDANIB, |
||||
| 32 | 25142837 |
HR |
69 | 1 |
Small intestine gangrene, Small intestinal perforation, Abdominal pain, Pneumonia, Stoma site discharge, Ileus, |
||||
| 33 | 25144747 |
|||
Diarrhoea, Abdominal pain, |
||||
EMPAGLIFLOZIN, |
||||
| 34 | 25138571 |
IL |
2 | |
Intestinal obstruction, Abdominal pain, Dyschezia, Faeces hard, Asthenia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 35 | 25138601 |
CA |
66 | 2 |
Haemoglobin decreased, Abdominal pain, Haematochezia, Faeces discoloured, Diarrhoea, |
||||
UPADACITINIB, |
||||
| 36 | 25137152 |
FR |
54 | 1 |
Abdominal pain, Hallucination, Unevaluable event, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 37 | 25137669 |
US |
80 | 1 |
Abdominal pain, Abdominal distension, Abdominal pain upper, Flatulence, Rectal tenesmus, |
||||
POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, ATENOLOL, |
||||
| 38 | 25137698 |
US |
75 | 1 |
Urinary retention, Lethargy, Faeces soft, Hypotension, Urinary tract infection, Dizziness, Arthralgia, Asthenia, Hot flush, Abdominal pain, Back pain, Musculoskeletal stiffness, |
||||
FINASTERIDE, RELUGOLIX, RELUGOLIX, |
||||
| 39 | 25138107 |
US |
||
Clostridium difficile infection, Clostridium test positive, Abdominal pain, Diarrhoea, Abdominal discomfort, Nausea, |
||||
FECAL MICROBIOTA SPORES, LIVE-BRPK, FECAL MICROBIOTA SPORES, LIVE-BRPK, |
||||
| 40 | 25132278 |
US |
2 | |
Constipation, Peripheral swelling, Joint swelling, Abdominal pain, |
||||
ALECTINIB HYDROCHLORIDE, |
||||
| 41 | 25132292 |
CA |
67 | 2 |
Crohn^s disease, Loss of personal independence in daily activities, Abdominal pain, Fatigue, Asthenia, Nausea, Vomiting, |
||||
ADALIMUMAB-RYVK, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB-RYVK, |
||||
| 42 | 25132306 |
CA |
69 | 2 |
Abdominal distension, Abscess limb, Alopecia, Arthralgia, Breast abscess, Faeces soft, General physical health deterioration, Large intestine polyp, Subcutaneous abscess, Inappropriate schedule of product administration, Off label use, Abdominal pain, Dry eye, Fatigue, Myalgia, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 43 | 25132726 |
CA |
58 | 1 |
Haemoglobin abnormal, Rectal haemorrhage, Abdominal pain, |
||||
RISANKIZUMAB-RZAA, IRON, |
||||
| 44 | 25132936 |
US |
64 | 1 |
Renal cancer, Thyroid cancer, Nausea, Abdominal pain, Gastrooesophageal reflux disease, |
||||
ORAL SEMAGLUTIDE, LENVATINIB, |
||||
| 45 | 25133124 |
US |
37 | 1 |
Small intestinal obstruction, Small intestinal stenosis, Fistula, Large intestine perforation, Abdominal pain, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 46 | 25133527 |
ES |
||
Thrombocytopenia, Neutropenia, Leukopenia, Neuropathy peripheral, Unevaluable event, Insomnia, Off label use, Stress, Anxiety, Cough, Dyspnoea, Weight decreased, Anaemia, Chest pain, Fatigue, Nausea, Decreased appetite, Constipation, Vomiting, Ageusia, Alopecia, Mucosal inflammation, Oral pain, Depression, Dry skin, Dry mouth, Diarrhoea, Pyrexia, Influenza like illness, Myalgia, Rash, Arthralgia, Dyspnoea, Fluid retention, Abdominal pain, Headache, Mood altered, Infection, |
||||
DENOSUMAB, BEVACIZUMAB, |
||||
| 47 | 25133549 |
CA |
54 | 1 |
Colitis ulcerative, Defaecation urgency, Abdominal pain, Therapeutic reaction time decreased, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VALACYCLOVIR HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 48 | 25133551 |
CA |
||
White blood cell count increased, Rheumatic fever, X-ray abnormal, Lung disorder, Laryngitis, Grip strength, Pneumonia, Visual impairment, Stomatitis, Weight increased, Joint range of motion decreased, Bone erosion, Irritable bowel syndrome, Lupus-like syndrome, Systemic lupus erythematosus, Muscle injury, Impaired healing, Dyspnoea, Hepatic enzyme increased, Abdominal pain upper, Headache, Oedema, Loss of personal independence in daily activities, Dizziness, Night sweats, Weight fluctuation, Swollen joint count increased, Pancreatitis, Rectal haemorrhage, Rheumatoid arthritis, Decreased appetite, Obesity, Laboratory test abnormal, Weight decreased, Diarrhoea, Gait disturbance, Glossodynia, Hand deformity, Exostosis, Mobility decreased, Liver disorder, Musculoskeletal stiffness, Sciatica, General physical health deterioration, Adjustment disorder with depressed mood, Depression, Arthritis, Facet joint syndrome, Insomnia, Lip dry, Vomiting, Discomfort, Hepatic cirrhosis, Folliculitis, Inflammation, Pyrexia, Liver injury, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Peripheral swelling, Oedema peripheral, Pain, Fibromyalgia, Wound, Hypoaesthesia, Condition aggravated, Gastrointestinal disorder, Nasopharyngitis, Feeling hot, Memory impairment, Delirium, Swollen joint count, Breast cancer stage III, Asthma, Porphyria acute, Paraesthesia, Foot deformity, Wheezing, Synovitis, Ill-defined disorder, Arthralgia, Dry mouth, Crohn^s disease, Muscle spasms, Muscular weakness, Rash, Chest pain, Contusion, Infusion related reaction, Peripheral venous disease, Rheumatoid factor positive, Duodenal ulcer perforation, Migraine, Abdominal discomfort, Hypertension, Osteoarthritis, Sinusitis, Pruritus, Grip strength decreased, Asthenia, Type 2 diabetes mellitus, Fatigue, Musculoskeletal pain, Sleep disorder due to general medical condition, insomnia type, Pemphigus, Sleep disorder due to a general medical condition, Abdominal pain, Pulmonary fibrosis, C-reactive protein abnormal, Blood cholesterol increased, Hypersensitivity, Nausea, Joint swelling, Arthropathy, Swelling, Blister, Walking aid user, Drug hypersensitivity, Amnesia, Retinitis, Bursitis, Osteoporosis, Anxiety, Dyspepsia, Frequent bowel movements, Urticaria, Hypercholesterolaemia, Injury, Colitis ulcerative, Psoriatic arthropathy, Malaise, Lupus vulgaris, Confusional state, Dislocation of vertebra, Road traffic accident, Alopecia, Pericarditis, Infection, Ear infection, Lower respiratory tract infection, Wound infection, Helicobacter infection, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, SECUKINUMAB, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERYTHROMYCIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, HYALURONIDASE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LORAZEPAM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MESALAMINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, RITUXIMAB, RITUXIMAB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CAFFEINE, MELOXICAM, MORPHINE, MAGNESIUM, USTEKINUMAB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, INFLIXIMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, |
||||
| 49 | 25133753 |
CA |
41 | 2 |
Pneumonia, Atelectasis, Blood sodium decreased, Blood potassium decreased, White blood cell count increased, C-reactive protein increased, Diarrhoea, Abdominal pain, Chest pain, |
||||
ADALIMUMAB-BWWD, METHOTREXATE, METHOTREXATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FOLIC ACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISONE, |
||||
| 50 | 25133766 |
IN |
39 | 2 |
Drug intolerance, Peritonitis, Abdominal pain, Treatment noncompliance, Hypotension, |
||||
| 51 | 25133821 |
AU |
61 | 2 |
Mesenteric artery stenosis, Nausea, Abdominal pain, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, RANITIDINE, HYDROXYUREA, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 52 | 25133979 |
CA |
79 | 1 |
Malignant melanoma, Faeces soft, Off label use, Abdominal pain, Arthralgia, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, AMLODIPINE, CHOLESTYRAMINE, |
||||
| 53 | 25134177 |
US |
||
Abdominal distension, Abdominal pain, Product prescribing issue, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 54 | 25134413 |
US |
44 | 2 |
Hereditary angioedema, Hereditary angioedema, Abdominal pain, Product dose omission issue, |
||||
| 55 | 25134569 |
US |
79 | 2 |
Vulvovaginal pain, Gait disturbance, Eating disorder, Vulvovaginal burning sensation, Swelling, Abdominal pain, Pruritus, Product use in unapproved indication, |
||||
NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 56 | 25134633 |
US |
||
Pain, Hormone level abnormal, Peripheral swelling, Abdominal pain, Headache, Fatigue, Product substitution issue, |
||||
LEVONORGESTREL, |
||||
| 57 | 25134926 |
US |
1 | |
Nausea, Diarrhoea, Vomiting, Abdominal pain, Decreased appetite, Dyspepsia, Fatigue, Eructation, |
||||
DULAGLUTIDE, |
||||
| 58 | 25135465 |
CN |
||
Palpitations, Blood pressure increased, Abdominal pain, Nausea, Vomiting, Asthenia, |
||||
SUNITINIB MALATE, SUNITINIB MALATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 59 | 25135516 |
IT |
16 | 2 |
Neuropathy peripheral, Abdominal pain, Nausea, Alopecia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 60 | 25135583 |
US |
||
Abdominal pain, Product dose omission in error, |
||||
DROSPIRENONE, |
||||
| 61 | 25136038 |
US |
24 | |
Impaired gastric emptying, Nausea, Vomiting, Abdominal pain, Diarrhoea, |
||||
TIRZEPATIDE, SEMAGLUTIDE, |
||||
| 62 | 25136435 |
CA |
42 | 1 |
Ileocaecal resection, Frequent bowel movements, Defaecation urgency, Weight increased, Faecal calprotectin increased, Drug ineffective, Abdominal pain, Haematochezia, |
||||
UPADACITINIB, |
||||
| 63 | 25136553 |
BR |
15 | 2 |
Disorientation, Hallucination, auditory, Mental disorder, Abdominal pain, Diarrhoea, Off label use, |
||||
ORAL SEMAGLUTIDE, |
||||
| 64 | 25136580 |
CN |
67 | 1 |
Pneumonia, Tumour rupture, Tumour haemorrhage, Renal failure, Abdominal pain, Haematuria, |
||||
SORAFENIB, TEMOZOLOMIDE, TEMOZOLOMIDE, BEVACIZUMAB, |
||||
| 65 | 25136795 |
SK |
59 | 1 |
C-reactive protein increased, Abdominal pain, |
||||
INCLISIRAN, |
||||
| 66 | 25136810 |
GB |
23 | 2 |
Biliary colic, Cholelithiasis, Abdominal pain, |
||||
TIRZEPATIDE, |
||||
| 67 | 25136826 |
GB |
||
Liver function test increased, Abdominal pain, |
||||
TIRZEPATIDE, |
||||
| 68 | 25136827 |
AU |
36 | 2 |
Hypokalaemia, Gastrointestinal sounds abnormal, Impaired gastric emptying, Dehydration, Nausea, Vomiting, Abdominal pain upper, Abdominal pain, Abdominal distension, Diarrhoea, Constipation, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, RISDIPLAM, PREGABALIN, SERTRALINE HYDROCHLORIDE, |
||||
| 69 | 25136905 |
CA |
74 | 1 |
Immune-mediated hepatitis, Abdominal pain, Cholangitis, Hepatic enzyme increased, |
||||
PEMBROLIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PREDNISONE, |
||||
| 70 | 25137000 |
US |
2 | |
Diabetic foot infection, Body mass index increased, Nausea, Vomiting, Abdominal pain, Blood glucose decreased, Off label use, |
||||
TIRZEPATIDE, DULAGLUTIDE, AMLODIPINE, CARVEDILOL, LISINOPRIL, GABAPENTIN, GABAPENTIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, SERTRALINE, |
||||
| 71 | 25137122 |
FI |
||
Large intestinal ulcer, Faecal calprotectin decreased, Abdominal pain, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, |
||||
| 72 | 25126289 |
IT |
61 | 1 |
Pyrexia, Abdominal pain, Mantle cell lymphoma, Hyperbilirubinaemia, |
||||
IBRUTINIB, |
||||
| 73 | 25126443 |
CN |
72 | 1 |
Diarrhoea, Abdominal pain, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, TIGECYCLINE, |
||||
| 74 | 25126527 |
US |
61 | |
Impaired gastric emptying, Nausea, Vomiting, Abdominal pain, Diarrhoea, |
||||
DULAGLUTIDE, DULAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 75 | 25126550 |
US |
33 | 1 |
Bacterial sepsis, Loss of consciousness, Abdominal pain, Confusional state, Dizziness, Staphylococcus test positive, Hypotension, Fall, Clostridium test positive, Haemophagocytic lymphohistiocytosis, Cytokine release syndrome, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACYCLOVIR, DAPSONE GEL, 5%, DAPSONE, DASPONE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FENTANYL, GABAPENTIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LORAZEPAM, METHADONE, METHOCARBAMOL, METHOCARBAMOL TABLETS, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIRTAZAPINE, OXYCODONE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, SENNA, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ALLOPURINOL, CEFEPIME HYDROCHLORIDE, CEFEPIME, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MICAFUNGIN, MICAFUNGIN SODIUM, HYDROCORTISONE ACETATE, HYDROCORTISONE, LETERMOVIR, RUXOLITINIB, ALBUMIN HUMAN, PROCHLORPERAZINE, |
||||
| 76 | 25126699 |
CO |
77 | 2 |
Abdominal pain, Heart valve operation, Dizziness, Vomiting, Off label use, |
||||
ROTIGOTINE, LOSARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, WARFARIN, PREGABALIN, BISOPROLOL FUMARATE, FUROSEMIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, |
||||
| 77 | 25127272 |
CA |
63 | 2 |
Abdominal pain, Pruritus, Flushing, Dyspnoea, Hallucination, visual, Rash, Urticaria, |
||||
CISPLATIN, DIPHENHYDRAMINE HYDROCHLORIDE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RANITIDINE, |
||||
| 78 | 25127297 |
US |
24 | 2 |
Uterine scar, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Anxiety, Abnormal uterine bleeding, Abdominal pain, Dysmenorrhoea, Device expulsion, |
||||
COPPER, |
||||
| 79 | 25127350 |
CZ |
45 | 1 |
Nausea, Chills, Dyspnoea, Abdominal pain, Dizziness, Dizziness, Dizziness, Back pain, Headache, Arthralgia, Application site mass, Application site mass, Application site mass, Application site pain, Application site pain, Application site pain, |
||||
DUPILUMAB, |
||||
| 80 | 25127467 |
CA |
77 | 2 |
Cholelithiasis, Migraine, Dyspnoea exertional, Abdominal pain, Pain, |
||||
ATOGEPANT, FROVATRIPTAN SUCCINATE, ONABOTULINUMTOXINA, |
||||
| 81 | 25127706 |
US |
26 | 2 |
Uterine leiomyoma, Hysterectomy, Laparotomy, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Sexual dysfunction, Procedural pain, Vulvovaginal pain, Anxiety, Device dislocation, Abdominal pain, Pain, Dyspareunia, Abnormal uterine bleeding, |
||||
COPPER, |
||||
| 82 | 25127707 |
US |
37 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Device dislocation, Abnormal uterine bleeding, Dyspareunia, Dysmenorrhoea, Abdominal pain, |
||||
COPPER, |
||||
| 83 | 25127769 |
US |
39 | 2 |
Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Embedded device, Anxiety, Abdominal pain, |
||||
COPPER, |
||||
| 84 | 25127772 |
US |
51 | 2 |
Abortion spontaneous, Device breakage, Foreign body in reproductive tract, Complication of device removal, Fear, Anxiety, Feeling abnormal, Emotional disorder, Sensation of foreign body, Pain, Abdominal distension, Muscle spasms, Pelvic discomfort, Abdominal pain, Pelvic pain, |
||||
COPPER, |
||||
| 85 | 25127834 |
US |
36 | 2 |
Appendicitis, Hydrosalpinx, Hysterectomy, Salpingo-oophorectomy, Salpingectomy, Muscle injury, Reproductive complication associated with device, Device breakage, Foreign body in reproductive tract, Complication of device removal, Pelvic inflammatory disease, Pelvic infection, White blood cell count increased, Dyspepsia, Scar, Emotional disorder, Abdominal pain lower, Muscle spasms, Pelvic pain, Device dislocation, Abdominal pain, |
||||
COPPER, |
||||
| 86 | 25127882 |
BE |
30 | 2 |
Cold sweat, Chills, Sensation of foreign body, Nausea, Abdominal pain, Vomiting, Fatigue, Asthenia, Labelled drug-drug interaction issue, |
||||
ORAL SEMAGLUTIDE, BISOPROLOL FUMARATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE, |
||||
| 87 | 25128014 |
US |
2 | |
Dry mouth, Abdominal pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 88 | 25128092 |
BR |
62 | 2 |
Erosive oesophagitis, Abdominal pain, Hypercholesterolaemia, Gastrooesophageal reflux disease, Depression, Hypertension, |
||||
DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, VONOPRAZAN FUMARATE, RISPERIDONE, ROSUVASTATIN, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 89 | 25128111 |
BR |
13 | 1 |
Suicide attempt, Overdose, Somnolence, Pallor, Vomiting, Somnolence, Abdominal pain, Tachycardia, |
||||
EMPAGLIFLOZIN, PASSIFLORA INCARNATA FLOWERING TOP, PASSIFLORA INCARNATA, LITHIUM CARBONATE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LOSARTAN, SERTRALINE, SERTRALINE, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, |
||||
| 90 | 25128238 |
US |
2 | |
Partial seizures, Haematochezia, Nausea, Vomiting, Headache, Abdominal pain, |
||||
SEMAGLUTIDE, |
||||
| 91 | 25128253 |
CA |
51 | 1 |
Nephrolithiasis, Abdominal pain, Flank pain, Haematuria, |
||||
OFATUMUMAB, |
||||
| 92 | 25128388 |
US |
||
Abdominal pain, |
||||
LINACLOTIDE, |
||||
| 93 | 25128892 |
8 | 1 | |
Seizure, Abdominal pain, Neutrophil count decreased, Pneumonia, |
||||
CARBOPLATIN, VINCRISTINE SULFATE, |
||||
| 94 | 25128968 |
US |
2 | |
Abdominal pain, |
||||
CARBOPLATIN, MELPHALAN HYDROCHLORIDE, ETOPOSIDE, |
||||
| 95 | 25129078 |
PT |
47 | 2 |
Asthenia, Diarrhoea, Abdominal pain, Myalgia, |
||||
TERIFLUNOMIDE, |
||||
| 96 | 25129111 |
US |
2 | |
Abdominal pain, Diarrhoea, Drug interaction, Injection site bruising, Wrong technique in product usage process, |
||||
CALCIUM CARBONATE, ERGOCALCIFEROL, ALENDRONATE SODIUM, FOLIC ACID, METHOTREXATE SODIUM, RITUXIMAB, |
||||
| 97 | 25129334 |
US |
66 | 2 |
Contraindicated product administered, Contusion, Eye pain, Vision blurred, Aspartate aminotransferase increased, Alanine aminotransferase increased, Pancreatitis, Nephrolithiasis, Lipase increased, Product dose omission issue, Lacrimation increased, Amblyopia, Abdominal pain, Fluid retention, Blood albumin decreased, Product use in unapproved indication, Drug ineffective for unapproved indication, Cataract, |
||||
METHOTREXATE, METHOTREXATE SODIUM, LEVOTHYROXINE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, TOPIRAMATE, TOPIRAMATE SPINKLE, ZIPRASIDONE, GABAPENTIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PREDNISONE, ONABOTULINUMTOXINA, SUMATRIPTAN, BUPROPION HYDROCHLORIDE, METHOCARBAMOL, METHOCARBAMOL TABLETS, SERTRALINE, |
||||
| 98 | 25129408 |
US |
2 | |
Abdominal pain, |
||||
RISANKIZUMAB-RZAA, |
||||
| 99 | 25129918 |
1 | ||
Abdominal pain, |
||||
RISANKIZUMAB-RZAA, |
||||
| 100 | 25130126 |
KR |
9 | 2 |
Anaphylactic reaction, Hypotension, Abdominal pain, Vision blurred, |
||||
METHOTREXATE SODIUM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28